Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.3772
-0.0227 (-5.68%)
At close: Aug 17, 2026, 4:00 PM EDT
0.385349
+0.0081 (2.16%)
After-hours: Aug 17, 2026, 7:46 PM EDT

Cytosorbents Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
37.2237.0635.631.0834.6943.17
Revenue Growth
3.07%4.12%14.51%-10.39%-19.64%5.27%
Gross Profit
26.6526.4924.8921.9520.7332.12
Operating Income
-11.77-14.24-16.45-31.95-30.89-22.74
Net Income
-18.21-8.2-20.72-29.25-32.81-24.56
Earnings Per Share
-0.29-0.13-0.38-0.65-0.75-0.57
EPS Growth
------

Revenue by Geography

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
0.440.250.150.076.34.75
Germany
10.7511.7513.0512.9612.5721.01
ALL Other Countries
26.0225.0622.3918.0515.8217.41
Total
37.2237.0635.631.0834.6943.17

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.416.253.2814.1322.1452.14
Total Debt
29.4329.1126.8918.3118.2513.82
Net Cash (Debt)
-25.01-22.86-23.61-4.183.8938.32
Net Cash Growth
-----89.84%-45.57%
Net Cash Per Share
-0.40-0.37-0.43-0.090.090.88

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.15-12.38-14.43-21.66-28.23-14.01
Capital Expenditures
-0.15-0.16-0.28-0.54-6.09-3.64
Free Cash Flow
-9.3-12.54-14.71-22.19-34.32-17.65
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
71.61%71.47%69.92%70.62%59.77%74.41%
Operating Margin
-31.63%-38.42%-46.22%-102.78%-89.04%-52.69%
Pretax Margin
-50.02%-23.20%-62.96%-96.70%-97.74%-58.60%
Profit Margin
-48.94%-22.12%-58.21%-94.09%-94.59%-56.89%
FCF Margin
-24.98%-33.84%-41.33%-71.39%-98.94%-40.88%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.641.081.401.861.954.22